Adult embryonal rhabdomyosarcoma in the nasal cavity; a case report with a review of the literature

Fatah, Mariwan L.; Salh, Abdulwahid M.; Abdullah, Ari M.; Kakamad, Fahmi H.; Mustafa, Suzana; Kakamad, Suhaib H.

doi:10.1016/j.amsu.2022.103424

Cited by 1 publication

(1 citation statement)

References 17 publications

(15 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nasal acinar rhabdomyosarcoma, one of the histopathological types of rhabdomyosarcoma, has rapid disease progression and high mortality. Therefore, the treatment of rhabdomyosarcoma requires a combination of surgery, chemotherapy, radiotherapy and immunotherapy to work together to achieve the best care for the patients [3] . Surgical resection is usually the first step in managing rhabdomyosarcoma, followed by chemotherapy and/or other treatment modalities decided on a case-by-case basis.…”

Section: Discussionmentioning

confidence: 99%

Rhabdomyosarcoma of the nasal cavity: a case report

Huang

Deng

2023

European Journal of Case Reports in Internal Medicine

View full text Add to dashboard Cite

Introduction: Rhabdomyosarcoma is a high-grade malignant neoplasm with skeletal muscle differentiation; a common soft tissue sarcoma in children but considered one of the rarest in adults. Case description: We report a case of 35-year-old male with a chronic productive cough and haemoptysis for five days. A CT scan of the nasopharynx revealed a blocked left maxillary and ethmoid sinus with bone destruction. These findings raised a suspicion of a tumour, and trans-nasal endoscopic sinus surgery was performed. Discussion: Nasal rhabdomyosarcoma is a rare adult malignant tumour. Most patients have lymphatic metastasis or skull base tumour infiltration at the time of the initial diagnosis and treatment, which poses a challenge to the diagnosis and management. Conclusion: Nasal acinar rhabdomyosarcoma, one of the histopathological types of rhabdomyosarcoma, has rapid disease progression and high mortality. Therefore, the treatment of rhabdomyosarcoma requires a combination of surgery, chemotherapy, radiotherapy, and immunotherapy to work together to achieve the best care for the patient.

show abstract

Section: Discussionmentioning

confidence: 99%